NPS Pharmaceuticals Inc (NASDAQ:NPSP) posted its quarterly earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.04, American Banking & Market News reports. The company had revenue of $44.04 million for the quarter, compared to the consensus estimate of $48.30 million. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) net profit margin is -8.70% and weekly performance is -0.11%. On last trading day company shares ended up $27.52. Analysts mean target price for the company is $43.29. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) distance from 50-day simple moving average (SMA50) is -4.97%
GrubHub Inc. (NYSE:GRUB) the leading online and mobile food-ordering company, announced financial results for the quarter ended March 31, 2014. GrubHub Inc (NYSE:GRUB) shares fell -0.51% in last trading session and ended the day on $31.22. Its return on assets is 0.50%.
Shutterstock, Inc. (NYSE:SSTK) announced its selection as a partner application for the launch of Radian6 Buddy Media Social Studio, the collaborative social content marketing, social engagement, publishing and analytics solution from the Salesforce ExactTarget Marketing Cloud. Shutterstock’s featured app will bring millions of images to the Radian6 Buddy Media Social Studio, helping companies explore and select high-quality, commercially licensable images for their social posts. Shutterstock Inc (NYSE:SSTK) shares moved down -1.01% in last trading session and was closed at $67.35, while trading in range of $60.01 – $67.35 -. Shutterstock Inc (NYSE:SSTK) year to date (YTD) performance is -19.47%.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a leading RNAi therapeutics company, announced that management will present a company overview at the Bank of America Merrill Lynch 2014 Health Care Conference on Thursday, May 15, 2014 at 9:20 a.m. PT (12:20 p.m. ET) at Encore at Wynn in Las Vegas. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) ended the last trading day at $54.33. Company weekly volatility is calculated as 7.20% and price to cash ratio as 14.12. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) showed a positive weekly performance of 0.22%.